1 patent currently held
96 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Dec 2040. from the record
Of the 96 now held by other companies, 75 were conveyed to Merck Sharp and Dohme LLC in the filing they arrived in, and 21 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Dec 2040
Next term end
1
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.
Formerly held, still cited
Notable
Ends Dec 2035 · High confidence
Cited by 17 later US patents, top 25% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2035.
conveyed to Wuxi Apptec Hong Kong Limited - now held by Lighthouse Pharmaceuticals, Inc.
Also notable
Ends Sep 2037 · Medium confidence
A family of 5 related applications built on the 2020 grant. Protection runs to 2037.
conveyed to Wuxi Apptec Hong Kong Limited - now held by Lighthouse Pharmaceuticals, Inc.
Also notable
Ends Oct 2036 · High confidence
The newest of the three, granted 2021. It anchors the portfolio to 2036, later than anything else here.
conveyed to Merck Sharp and Dohme Corp. - now held by Merck Sharp & Dohme LLC
Fee deadlines
No maintenance fee falls due on this company's record before Nov 17, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first.
Showing 1 to 1 of 1
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D1,107,941 | Drug screening instrument In force · High confidence | In force | High confidence |
Also on record, not counted in the 1: 96 patents in force now held by others · 4 patents ended · 10 applications pending · 23 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
7 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
6 computed term dates come from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.